Johnson & Johnson acquired Novira Therapeutics

[sarrah1992]

Johnson & Johnson announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.  The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778.  Financial terms of the transaction have not been disclosed.

http://www.marketwatch.com/story/johnson-johnson-announces-agreement-to-acquire-novira-therapeutics-inc-2015-11-04

More and More competition its always good. what do you thing of novira's NVR 3-778? do you think it might contribute to a final cure?

[March06]

i think still they are in phase "Produces Deep and Durable Knockdown" so they are far from contributing a cure.

[needadvicewithhep]

Havent read the link the only way to determine weather its good or not is dependant on which direction johnson and johnson take the company only time will really tell